Quantitative study on dose distribution of Freiburg flap for keloid high-dose-rate brachytherapy based on MatriXX

J Appl Clin Med Phys. 2023 Sep;24(9):e14118. doi: 10.1002/acm2.14118. Epub 2023 Aug 18.

Abstract

Purpose: To quantify the dose distribution effect of insufficient scattering conditions in keloid HDR brachytherapy with Freiburg fFlap (FF) applicator.

Materials and methods: A phantom composed of FF applicator, MatriXX and solid water slices was designed and scanned for treatment planning. Bolus with different thicknesses were covered to offer different scatter conditions. Planar dose distributions were measured by MatriXX. The maximum value (Max), average value (Avg) and γ passing rate (3 mm/3%) were evaluated by the software MyQA Platform.

Results: The maximum and average doses measured by MatriXX were lower than the calculated values. The difference increased as field size decreased. The Max value, found at 0.86 cm level in the two tube case, was -20.0%, and the avg value was -11.9%. All the γ values were less than 95%. This difference gradually decreased with increasing bolus thickness and the γ values were significantly improved.

Conclusion: MatriXX could be used for dose verification of HDR brachytherapy with an FF applicator. When the FF applicator was applied for keloid, insufficient scattering conditions would cause an insufficient target dose. This difference could be reduced by covering the bolus with different thicknesses on the applicator. The smaller the field, the thicker the bolus required.

Keywords: HDR brachytherapy; MatriXX; dose verification.

MeSH terms

  • Brachytherapy*
  • Gamma Rays
  • Humans
  • Keloid* / radiotherapy
  • Phantoms, Imaging
  • Software